A modern view of LGL leukemia.
Marchand T, Lamy T, Loughran TP Jr.
Blood. 2024 Oct 31;144(18):1910-1923. doi: 10.1182/blood.2023021790.
Epstein-Barr virus-associated T- and NK-cell lymphoproliferative diseases: an update and diagnostic approach.
Hue SS, Oon ML, Wang S, Tan SY, Ng SB.
Pathology. 2020 Jan;52(1):111-127. doi: 10.1016/j.pathol.2019.09.011. Epub 2019 Nov 22.
[Clinical Characteristics of Aggressive NK-Cell Leukemia].
Liao Y, He HS, Wei YF, Shen DP, Ji XY, Huang C, Huang J, Jin XK, Huang DP.
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2023 Aug;31(4):1026-1031. doi: 10.19746/j.cnki.issn.1009-2137.2023.04.015.
LGL leukemia: from pathogenesis to treatment.
Lamy T, Moignet A, Loughran TP Jr.
Blood. 2017 Mar 2;129(9):1082-1094. doi: 10.1182/blood-2016-08-692590. Epub 2017 Jan 23.
Single-cell RNA sequencing coupled to TCR profiling of large granular lymphocyte leukemia T cells.
Gao S, Wu Z, Arnold B, Diamond C, Batchu S, Giudice V, Alemu L, Raffo DQ, Feng X, Kajigaya S, Barrett J, Ito S, Young NS.
Nat Commun. 2022 Apr 11;13(1):1982. doi: 10.1038/s41467-022-29175-x.
[Allogeneic stem cell transplantation for aggressive NK cell leukemia].
Fujimoto A.
Rinsho Ketsueki. 2021;62(5):360-368. doi: 10.11406/rinketsu.62.360.
Aggressive NK-cell leukemia with hemophagocytosis in a Caucasian patient.
Michaelis S, Pichler A, Stelzer I, Schöffmann L, Tinchon C, Enko D.
Ann Hematol. 2022 Mar;101(3):721-722. doi: 10.1007/s00277-021-04585-x. Epub 2021 Jul 16.
Efficacy and prognosis of allogeneic hematopoietic stem cell transplantation in aggressive NK-cell leukemia: a meta-analysis.
Cao S, Cao C, Wang S.
Ann Hematol. 2025 Jun;104(6):3433-3445. doi: 10.1007/s00277-025-06423-w. Epub 2025 Jun 5.
EBV-negative Aggressive NK-cell Leukemia/Lymphoma: Clinical, Pathologic, and Genetic Features.
Nicolae A, Ganapathi KA, Pham TH, Xi L, Torres-Cabala CA, Nanaji NM, Zha HD, Fan Z, Irwin S, Pittaluga S, Raffeld M, Jaffe ES.
Am J Surg Pathol. 2017 Jan;41(1):67-74. doi: 10.1097/PAS.0000000000000735.
Allogeneic stem cell transplantation for patients with aggressive NK-cell leukemia.
Fujimoto A, Ishida F, Izutsu K, Yamasaki S, Chihara D, Suzumiya J, Mitsui T, Doki N, Sakai H, Kobayashi H, Kanda J, Fukuda T, Atsuta Y, Suzuki R.
Bone Marrow Transplant. 2021 Feb;56(2):347-356. doi: 10.1038/s41409-020-01009-8. Epub 2020 Aug 10.
